首页 > 整体介绍 > 企业文化

Development Strategy

Focus on the development of immunocytokines to strengthen our leading position in this drug development field.
Continue advancing selected pipeline products with great clinical value and commercial potential.
Expanding our GMP-compliant manufacturing facility to enhance our production capabilities and starting to assemble a seasoned commercial team.
Actively seeking international collaboration opportunities to maximize value of our assets and increase brand awareness on a global scale .
Continue to focus on selecting and retaining top talents to fuel our innovation .

About SunHo: Company Profile; Corporate Culture; Development Strategy; Manufacturing Base

R&D Platform: Armed ImmunoCytokine Platform, AIC™; ADCC Enhanced Antibody Platform, AEA™; Armed Innate-effector Multispecific Platform, AIM™

Investor Relations: Listing Documents; Financial Reports; Announcements & Notices; Corporate Governance; IR Contact

搜索资讯